Back to News
Market Impact: 0.15
Quoin Pharmaceuticals, Ltd. Reports Third Quarter 2026 Financial Results
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Quoin Pharmaceuticals reported approximately $33.2 million in cash, cash equivalents and marketable securities as of September 30, 2026. The article excerpt says the company reported a net loss for the third quarter but provides no loss amount.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Binance CFO exits days after catastrophic $6 billion crypto hack
- Decisive election. Dramatic stock swings. How we handled the market last week
- Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline
- Berkshire shares surge as Wall Street swoons amid AI fears
- Paraguay’s ousted president charged over banking scandal
- CoreWeave seeks truce with Texas Governor-elect Hinojosa